Top View
- Appendix B - Product Name Sorted by Applicant
- Azedra® (Iobenguane I-131) (Intravenous) Last Review Date: January 1, 2020 Number: MG.MM.PH.127
- Radiochemistry, Production Processes, Labeling Methods, and Immunopet Imaging Pharmaceuticals of Iodine-124
- IAEA TECDOC SERIES Quality Control in the Production of Radiopharmaceuticals
- Muuttuneet Radiofarmaseuttiset INN-Nimet/1.1.2018
- Consultation Documents
- Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure
- Marrakesh Agreement Establishing the World Trade Organization
- SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0*
- Imaging Protocols Bildgebungsprotokolle Protocoles D’Imagerie
- Norepinephrine in Mouse Pheochromocytoma Cells and Tumors After Treatment with the Histone Deacetylase Inhibitors
- Contrast Agents and Radiopharmaceuticals
- EANM 2012 Guidelines for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma
- Nuclear Medicine: Looking Ahead to 2020
- 123-I MIBG Imaging: Patient Preparation and Technologist's Role
- Customs Tariff - Schedule Xxi - 1
- I-131 Meta-Iodobenzylguanidine (Iobenguane Sulfate) (MIBG)
- 022454Orig1s000
- Monographs for Individual Radiopharmaceutical Preparations (September 2007)
- (12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Chapter 4 Quality Assurance of Radiopharmaceuticals 4
- Public Assessment Report
- Adverse Reactions to Radiopharmaceuticals (ARRP): Particularly to Technetium Radiopharmaceuticals
- 2005 Physicians Fee Schedule (PFS) for Nuclear Medicine Related Drugs
- Reference ID: 3279800 FULL PRESCRIBING INFORMATION
- Adverse Events of Diagnostic Radiopharmaceuticals: a Systematic Review Nanno Schreuder, Pharmd,*,† Danielle€ Koopman, Msc,ǂ,{ Pieter L
- Radiopharmaceuticals in Cardiology
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- SPECT Nuclear Imaging White Paper
- Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
- Workshop Outcome and Recommendations
- Radiotracers for SPECT Imaging: Current Scenario and Future Prospects
- Information Resources
- Iobenguane I 131) Injection, for Intravenous Use Ranged from 12 Months to 7 Years
- Nuclear Medicine Imaging